Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Takeda Pharmaceutical Company

United States — Food and Drug Administration & Takeda Pharmaceutical Company

2 shared events · Importance 3 · Last updated Jun 17, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
14
Business
Protagonist Therapeutics Grants Employee Awards
United States — Food and Drug Administration: The United States — Food and Drug Administration is currently reviewing the New Drug Application for rusfertide for the treatment of polycythemia vera.
Takeda Pharmaceutical Company: Takeda Pharmaceutical Company is licensed to develop and commercialize rusfertide, another peptide therapeutic discovered by AnBogen Therapeutics.
Jun 16, 2026 · 6 articles
0
Tech
Blood Test Predicts Alzheimer's Onset
Takeda Pharmaceutical Company: Takeda Pharmaceutical Company Limited is a funding partner for the project, supporting the research into Alzheimer s disease biomarkers.
Feb 19, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Takeda Pharmaceutical Company interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.